Screener
ANI Pharmaceuticals ANIP Interest rate swap derivative financial instruments
Interest rate swap derivative financial instruments at other companies
Other financials
Where this comes from
Reported directly by ANI Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:InterestRateDerivativeAssetsAtFairValue.
The source filing: ANI Pharmaceuticals’s 10-Q, filed August 7, 2026. Open the filing →
- Filed
- Aug 7, 2026, 7:01 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001023024-26-000069
FAQ
- What is ANI Pharmaceuticals's interest rate swap derivative financial instruments?
- ANI Pharmaceuticals (ANIP) reported interest rate swap derivative financial instruments of $1.12M in Q2 2026.
- How has ANI Pharmaceuticals's interest rate swap derivative financial instruments changed year-over-year?
- ANI Pharmaceuticals's interest rate swap derivative financial instruments decreased by 60.0% year-over-year, from $2.81M to $1.12M.
- What is the long-term trend for ANI Pharmaceuticals's interest rate swap derivative financial instruments?
- Over 3 years (2022 to 2025), ANI Pharmaceuticals's interest rate swap derivative financial instruments has grown at a -42.7% compound annual growth rate (CAGR), from $8.76M to $1.65M.
- What does interest rate swap derivative financial instruments mean?
- Interest rate swap derivative financial instruments as reported by ANI Pharmaceuticals, Inc..
Ask your AI about ANI Pharmaceuticals's interest rate swap derivative financial instruments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude